Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? - Test2 - elhamkhani - TriplyDB

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

http://www.wikidata.org/entity/Q27025083

about

Diagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and Developments Nutrition and Hepatocellular Cancer Hepatobiliary Tumors: Update on Diagnosis and Management Molecular prognostic prediction in liver cirrhosis Why does obesity promote cancer? Epidemiology, biology, and open questions Current concepts in the immunohistochemical evaluation of liver tumors Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma Pesticide exposure and liver cancer: a review Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review.Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis.Comparison of hepatocellular carcinoma in Eastern versus Western populations.HIV, Aging, and Viral Coinfections: Taking the Long View.Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.Hepatocellular carcinoma: early-stage management challenges Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis.Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database.Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinoma Hepatitis B virus epidemiology.Hepatitis C virus-induced hepatocellular carcinoma Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Intra-aortic balloon pump-assisted major hepatectomy in a case with coronary disease.Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.Sex and Ethnic Differences in the Association of Obesity With Risk of Hepatocellular Carcinoma.Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma Hepatitis C virus Genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk.Prognostic value of DNA repair based stratification of hepatocellular carcinoma OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based study Cyproheptadine use in hepatocellular carcinoma.Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.

P2860

Q26740315-5DC98D38-8433-4F61-B7DC-35D4DC7DB0C2 Q26741102-C768D7E2-5674-4B67-9B70-606CFCE7D737 Q26775654-8979CE6B-CCA0-47F1-9B05-88AB52F4827B Q26784251-AC848588-6488-46FE-8DDA-0BDC226B7310 Q26797301-D3F72D25-3D3E-408C-B6C6-732C725A6D17 Q26864205-82041F94-BC3B-4724-ADDA-7DB54758F43F Q27007847-D51BFACA-07B7-4B82-874F-254C8C935A70 Q28067445-6160B41C-BC15-4DF4-96F7-BA1204B119C5 Q28818507-04BF5346-F84F-482E-A90C-045A1A35410A Q29248103-2EDDF841-AB73-468A-A126-D6102C6BC48A Q30234676-777708CD-340E-44DB-B82E-72A9C39F3715 Q30241048-D391A047-1C75-47B1-8235-508AE8E9158B Q30245396-C1CB6C38-75FE-44F1-A0AC-7617AA4ADC35 Q30245486-56AE75E6-45F7-4A30-A70D-03458EEC6017 Q30248206-D87538A6-C109-42AA-B8E0-256D8A8E2729 Q33688583-4A90091E-F61A-4A42-A95A-4F554F969D1B Q33881131-DC764977-21C3-404D-8D11-753AA698B9C9 Q34758930-0EA1878C-6D1C-4BE6-AD12-F5FD1BA11DBD Q35073171-BBFACBB5-CBB6-42D4-9AD8-3C12B474698A Q35085189-49434EEF-AE28-4CFD-B2E6-2F2F8CC0D2AB Q35176097-1C4DE976-BEE9-41F7-8173-7ECF7D7BC5CF Q35234688-B337FC45-CA70-416E-807C-37269028662D Q35663834-2AF720A9-0544-4035-BE89-34B560896A6B Q35824057-B5E172E1-3876-4B32-BA78-807080D0AD95 Q35881575-3284F2A0-C258-45D6-A3D3-E28550BD3AB7 Q36009055-901380ED-A09C-40BC-B2E3-7FE69EF4E018 Q36078583-A04A3B5B-6E98-42C6-AFFF-91A56DA1B712 Q36144048-E558BDEB-486C-4DFC-B9FF-5C0AA695257B Q36199751-64864663-6A39-43ED-BF80-A23E54FA77B0 Q36241192-83C7C137-EE2D-4CBB-85A1-4C13730E4A22 Q36306768-AC33BA10-C6B5-4FB2-96F2-3778A8290266 Q36479561-5A1251A2-836A-4BEC-8026-38BFEF015793 Q36509109-DE84DE29-7812-4046-A7E4-9DADDC93A7A3 Q36871894-E2F83528-AF47-4486-B143-01A365E78014 Q36903275-98EFA771-A12C-41D7-B3B6-B77EC6E02379 Q37110450-8BBC0517-38F2-464C-AE82-859BF85B0E38 Q37256889-1C568B95-C306-4ED2-B530-379EF017DEDA Q37698565-1F55774B-EE66-4C26-942F-1122774E1B88 Q37743521-687EF4EB-5750-4497-957E-449221B8695A Q38366584-AA02BD0D-9C7A-48E0-BB4B-69C9F6E6A82A

P2860

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

http://www.wikidata.org/entity/Q27025083

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Epidemiology of hepatocellular ...... where are we? Where do we go?

@ast

Epidemiology of hepatocellular ...... where are we? Where do we go?

@en

Epidemiology of hepatocellular ...... where are we? Where do we go?

@nl

type

label

Epidemiology of hepatocellular ...... where are we? Where do we go?

@ast

Epidemiology of hepatocellular ...... where are we? Where do we go?

@en

Epidemiology of hepatocellular ...... where are we? Where do we go?

@nl

prefLabel

Epidemiology of hepatocellular ...... where are we? Where do we go?

@ast

Epidemiology of hepatocellular ...... where are we? Where do we go?

@en

Epidemiology of hepatocellular ...... where are we? Where do we go?

@nl

P1433

Q27025083-D7AA1C67-8FDA-48E2-98B4-D3526DC77F90

P1476

Q27025083-BB0B1E86-0189-4DC2-B468-1F2FDFE66001

P2093

Q27025083-6A474404-9C9F-4F09-933F-3B2BE4007AE6

Q27025083-D8180672-D20C-47BC-9120-D7CA134186A9

P2860

Q27025083-02DC1F0C-05BD-47A3-9D10-9A790D2714BF

Q27025083-0E374CE6-7F0C-429C-BDAC-9C804D131714

Q27025083-1B564842-D113-4F8A-9F0E-73D2A3601E02

Q27025083-1C678233-C60A-42D9-9F8B-7B283A0DEEC9

Q27025083-2AA716F8-75F8-4E33-BD2B-A0C296E36435

Q27025083-2B44FADF-E9AF-492F-A0EB-C472A9D992A8

Q27025083-2B8ACEA1-276C-4E0F-B953-DD9C8541E54A

Q27025083-3046C22F-76B7-475F-BF7E-A56D77164FA4

Q27025083-40D3DFFB-E7D7-405E-A9F3-2D1C7AB31687

Q27025083-4355C2F4-B8CE-4B68-A5B4-A370A9FBC65C

P304

Q27025083-8BBCAF1F-DC24-430A-8A93-DB0F234F9FE2

P31

Q27025083-CA729BBF-650E-4443-BA0B-0B1EBE922651

P3181

Q27025083-C77D657D-84ED-4020-A758-3EAC751F64E7

P356

Q27025083-49516079-CD60-4DD3-BAFB-3895F03D1E8E

P407

Q27025083-0DD0566E-D8AD-4314-BEAD-90D351661B15

P433

Q27025083-588F3485-2E8A-4C2B-B29D-9F40A3EB8303

P478

Q27025083-0900DD59-4345-4314-BF4F-952B11ACBFE8

P577

Q27025083-1005AB8F-CA9D-4B15-9A7B-4F9AB39A602A

P698

Q27025083-0A6E550E-106B-4532-8137-7A095B9C1BE6

P921

Q27025083-532520D5-22B0-4022-B9F9-1F2300A3F2C7

Q27025083-C4E26675-ED44-405C-AAB7-F8D0E132F687

P932

Q27025083-05FFC8F6-7B68-48C9-BAC1-92DC28350032

P3181

P356

P1433

P1476

Epidemiology of hepatocellular ...... where are we? Where do we go?

@en

P2093

Fasiha Kanwal

http://www.w3.org/2001/XMLSchema#string

Hashem B. El-Serag

http://www.w3.org/2001/XMLSchema#string

P2860

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

Moderate alcohol intake and cancer incidence in women

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

Hepatocellular carcinoma

Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma

Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.

Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis.

P304

1767-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1338071

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HEP.27222

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24839253

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

4211957

http://www.w3.org/2001/XMLSchema#string